{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:17:59Z","timestamp":1794863879152,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)","award":["Programa Pesquisador Visitante Especial (PVE #029\/2012)"],"award-info":[{"award-number":["Programa Pesquisador Visitante Especial (PVE #029\/2012)"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)","award":["CAPES, PVE #029\/2012"],"award-info":[{"award-number":["CAPES, PVE #029\/2012"]}]},{"name":"S\u00e3o Paulo Research Foundation (FAPESP)","award":["FAPESP, #2011\/09572-1"],"award-info":[{"award-number":["FAPESP, #2011\/09572-1"]}]},{"name":"S\u00e3o Paulo Research Foundation (FAPESP)","award":["FAPESP, #2012\/05754-1"],"award-info":[{"award-number":["FAPESP, #2012\/05754-1"]}]},{"name":"Diagnosticos da America - DASA"},{"name":"NAP-Biobanco\/USP"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2966-x","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T23:35:24Z","timestamp":1480721724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil"],"prefix":"10.1186","volume":"16","author":[{"given":"Simone","family":"Maistro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselly","family":"Encinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia Hirata","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Dionisio Tavares","family":"Niewiadonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Garcia","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Marques","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Gaburo Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Ribeiro Chaves","family":"de Gouv\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirce Maria","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester Cerdeira","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Pilar Estevez","family":"Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Chammas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida Hendrika","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-0919","authenticated-orcid":false,"given":"Maria Aparecida Azevedo Koike","family":"Folgueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,3]]},"reference":[{"key":"2966_CR1","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade, Instituto Nacional de C\u00e2ncer \u2013 INCA, 2016. http:\/\/www2.inca.gov.br\/wps\/wcm\/connect\/tiposdecancer\/site\/home\/ovario . Accessed 3 Jan 2016."},{"key":"2966_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"2966_CR3","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/cncr.21536","volume":"104","author":"T Pal","year":"2005","unstructured":"Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005;104:2807\u201316.","journal-title":"Cancer"},{"key":"2966_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","volume":"121","author":"S Zhang","year":"2011","unstructured":"Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, et al. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol. 2011;121:353\u20137.","journal-title":"Gynecol Oncol"},{"key":"2966_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ygyno.2011.10.027","volume":"124","author":"AO Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez AO, Llacuachaqui M, Pardo GG, Royer R, Larson G, Weitzel JN, et al. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia. Gynecol Oncol. 2012;124:236\u201343.","journal-title":"Gynecol Oncol"},{"key":"2966_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329\u201333.","journal-title":"J Clin Oncol"},{"key":"2966_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ygyno.2015.11.029","volume":"140","author":"JR Vos","year":"2016","unstructured":"Vos JR, Mourits MJ, Teixeira N, Jansen L, Oosterwijk JC, de Bock GH. Inverse birth cohort effects in ovarian cancer: Increasing risk in BRCA1\/2 mutation carriers and decreasing risk in the general population. Gynecol Oncol. 2016;140:289\u201394.","journal-title":"Gynecol Oncol"},{"key":"2966_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/annonc\/mdq628","volume":"22","author":"PM Vencken","year":"2011","unstructured":"Vencken PM, Kriege M, Hoogwerf D, Beugelink S, van der Burg ME, Hooning MJ, et al. Chemosensitivity and outcome of BRCA- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients. Ann Oncol. 2011;22:1346\u201352.","journal-title":"Ann Oncol"},{"key":"2966_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ygyno.2014.02.039","volume":"33","author":"JF Liu","year":"2014","unstructured":"Liu JF, Konstantinopoulos PA, Matulonis UA. PARP inhibitors in ovarian cancer: current status and future promise. Review. Gynecol Oncol. 2014;33:362\u20139.","journal-title":"Gynecol Oncol"},{"key":"2966_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.maturitas.2014.12.009","volume":"80","author":"CM Driel van","year":"2015","unstructured":"van Driel CM, de Bock GH, Arts HJ, Sie AS, Hollema H, Oosterwijk JC, et al. Stopping ovarian cancer screening in BRCA1\/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens. Maturitas. 2015;80:318\u201322.","journal-title":"Maturitas"},{"key":"2966_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057581","volume":"8","author":"DM Carraro","year":"2013","unstructured":"Carraro DM, Koike Folgueira MA, Garcia Lisboa BC, Ribeiro Olivieri EH, Vitorino Krepischi AC, de Carvalho AF, et al. Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS One. 2013;8, e57581.","journal-title":"PLoS One"},{"key":"2966_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2350-15-55","volume":"15","author":"FC Silva","year":"2014","unstructured":"Silva FC, Lisboa BC, Figueiredo MC, Torrezan GT, Santos EM, Krepischi AC, et al. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. BMC Med Genet. 2014;15:55.","journal-title":"BMC Med Genet"},{"key":"2966_CR13","doi-asserted-by":"crossref","unstructured":"Alemar B, Herzog J, Brinckmann Oliveira Netto C, Artigal\u00e1s O, Schwartz IV, Matzenbacher Bittar C, et al. Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations. Cancer Genet. 2016;209:417\u2013422.","DOI":"10.1016\/j.cancergen.2016.06.008"},{"key":"2966_CR14","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE) Database. http:\/\/www.censo2010.ibge.gov.br\/sinopse\/index.php?uf=35&dados=0 . Accessed 6 Jan 2016"},{"key":"2966_CR15","unstructured":"Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo Octavio Frias de Oliveira (ICESP). http:\/\/icesp.org.br\/ . Accessed 6 Jan 2016"},{"key":"2966_CR16","unstructured":"Human Genome Variation Society, HGVS. http:\/\/www.hgvs.org . Accessed 1 Oct 2015."},{"key":"2966_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"2966_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863\u201374.","journal-title":"Genome Res"},{"key":"2966_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jmg.2005.033878","volume":"43","author":"SV Tavtigian","year":"2006","unstructured":"Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2006;43:295\u2013305.","journal-title":"J Med Genet"},{"key":"2966_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7, e46688.","journal-title":"PLoS One"},{"key":"2966_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-B\u00e9roud G, Claustres M, B\u00e9roud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37, e67.","journal-title":"Nucleic Acids Res"},{"key":"2966_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56\u201365.1.","journal-title":"Nature"},{"key":"2966_CR23","unstructured":"Exome Aggregation Consortium (ExAC) Databases. http:\/\/exac.broadinstitute.org . Accessed 31 Nov 2015."},{"key":"2966_CR24","unstructured":"Global MAF dbSNP Databases. http:\/\/www.ncbi.nlm.nih.gov\/snp . Accessed 31 Nov 2015."},{"key":"2966_CR25","unstructured":"Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP) Databases. http:\/\/evs.gs.washington.edu\/EVS\/ . Accessed 31 Nov 2015."},{"key":"2966_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2966_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2012.20","volume":"307","author":"KL Bolton","year":"2012","unstructured":"Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA. 2012;307:382\u201390.","journal-title":"JAMA"},{"key":"2966_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1200\/JCO.2007.11.6905","volume":"26","author":"A Chetrit","year":"2008","unstructured":"Chetrit A, Hirsh-Yechezkel G, Ben-David Y, Lubin F, Friedman E, Sadetzki S. Effect of BRCA1\/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer. J Clin Oncol. 2008;26:20\u20135.","journal-title":"J Clin Oncol"},{"key":"2966_CR29","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313:1347\u201361.","journal-title":"JAMA"},{"key":"2966_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1471-2407-13-243","volume":"13","author":"P Blay","year":"2013","unstructured":"Blay P, Santamar\u00eda I, Pitiot AS, Luque M, Alvarado MG, Lastra A, et al. Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer. 2013;13:243.","journal-title":"BMC Cancer"},{"key":"2966_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-006-9370-1","volume":"103","author":"D Torres","year":"2007","unstructured":"Torres D, Rashid MU, Gil F, Umana A, Ramelli G, Robledo JF, Tawil M, Torregrosa L, Briceno I, Hamann U. High proportion of BRCA1\/2 founder mutations in Hispanic breast\/ovarian cancer families from Colombia. Breast Cancer Res Treat. 2007;103:225\u201332.","journal-title":"Breast Cancer Res Treat"},{"key":"2966_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1897-4287-9-12","volume":"9","author":"IP Ewald","year":"2011","unstructured":"Ewald IP, Izetti P, Vargas FR, Moreira MA, Moreira AS, Moreira-Filho CA, et al. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hered Cancer Clin Pract. 2011;9:12.","journal-title":"Hered Cancer Clin Pract"},{"key":"2966_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4172\/2157-2518.1000228","volume":"6","author":"LM Porchia","year":"2015","unstructured":"Porchia LM, Gonzalez-Mejia ME, Calderilla-Barbosa L, Ordaz-Diaz N, Islas F, et al. Common BRCA1 and BRCA2 Mutations among Latin American breast cancer subjects: a meta-analysis. J Carcinogene Mutagene. 2015;6:228.","journal-title":"J Carcinogene Mutagene"},{"key":"2966_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ejhg.2010.203","volume":"19","author":"N Hamel","year":"2011","unstructured":"Hamel N, Feng BJ, Foretova L, Stoppa-Lyonnet D, Narod SA, et al. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations. Eur J Hum Genet. 2011;19:300\u20136.","journal-title":"Eur J Hum Genet"},{"key":"2966_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cancergencyto.2008.03.011","volume":"184","author":"EC Costa da","year":"2008","unstructured":"da Costa EC, Vargas FR, Moreira AS, Louren\u00e7o JJ, Caleffi M, Ashton-Prolla P, et al. Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome. Cancer Genet Cytogenet. 2008;184:62\u20136.","journal-title":"Cancer Genet Cytogenet"},{"key":"2966_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1634\/theoncologist.2015-0416","volume":"21","author":"CA Ossa","year":"2016","unstructured":"Ossa CA, Torres D. Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review. Oncologist. 2016;21:832\u20139. Review.","journal-title":"Oncologist"},{"key":"2966_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cancergencyto.2005.07.005","volume":"168","author":"S Preisler-Adams","year":"2006","unstructured":"Preisler-Adams S, Sch\u00f6nbuchner I, Fiebig B, Welling B, Dworniczak B, Weber BH. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet. 2006;168:44\u20139.","journal-title":"Cancer Genet Cytogenet"},{"key":"2966_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/gcc.20342","volume":"45","author":"S Agata","year":"2006","unstructured":"Agata S, Viel A, Della Puppa L, Cortesi L, Fersini G, Callegaro M, et al. Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast\/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosomes Cancer. 2006;45:791\u20137.","journal-title":"Genes Chromosomes Cancer"},{"key":"2966_CR39","doi-asserted-by":"publisher","first-page":"14012","DOI":"10.1038\/hgv.2014.12","volume":"1","author":"GES Felix","year":"2014","unstructured":"Felix GES, Sandes CA, Machado-Lopes TMB, Bonfim TF, Guindalini RSC, Santos VCSAR, et al. Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian population. Hum Genome Var. 2014;1:14012.","journal-title":"Hum Genome Var"},{"key":"2966_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cancergen.2015.11.003","volume":"209","author":"H Schayek","year":"2016","unstructured":"Schayek H, De Marco L, Starinsky-Elbaz S, Rossette M, Laitman Y, Bastos-Rodrigues L, et al. The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil. Cancer Genet. 2016;209:50\u20132.","journal-title":"Cancer Genet"},{"key":"2966_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017063","volume":"6","author":"SD Pena","year":"2011","unstructured":"Pena SD, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy Fde S, et al. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One. 2011;6, e17063.","journal-title":"PLoS One"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2966-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2966-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2966-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:11:17Z","timestamp":1498353077000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2966-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2966"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2966-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"934"}}